Close
Back to REGN Stock Lookup

Regeneron (REGN) – Business Wire

Sep 20, 2023 09:00 AM AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
Sep 20, 2023 09:00 AM AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
Apr 26, 2023 04:05 PM Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Mar 28, 2023 07:30 AM Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
Oct 17, 2022 08:00 AM Immune-Onc Therapeutics Initiates Expansion Cohorts for IO-108 and Enters into Clinical Supply Agreement with Regeneron
Sep 15, 2022 07:00 AM Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Jun 14, 2021 08:01 AM Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
Nov 2, 2020 10:00 AM 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020
Oct 19, 2020 10:00 AM 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)

Back to REGN Stock Lookup